Home
Live Updates
Deciphera Pharmaceuticals to Present Data from INTRIGUE Phase 3 Study of QINLOCK® (ripretinib) and Trial-in-Progress Poster for INSIGHT Pivotal Phase 3 Study of QINLOCK® at the 2023 American Society of Clinical Oncology Annual Meeting : comparemela.com
Deciphera Pharmaceuticals to Present Data from INTRIGUE Phase 3 Study of QINLOCK® (ripretinib) and Trial-in-Progress Poster for INSIGHT Pivotal Phase 3 Study of QINLOCK® at the 2023 American Society of Clinical Oncology Annual Meeting
– Company Presents Poster on Overall Survival and Long-Term Safety Results from INTRIGUE Study; Second Poster Presents Analysis from INTRIGUE Patients without Detectable ctDNA at Baseline... | May 25, 2023
Related Keywords
Germany ,
Australia ,
Israel ,
Hong Kong ,
Switzerland ,
Chicago ,
Illinois ,
United States ,
Macau ,
United Kingdom ,
Canada ,
Taiwan ,
China ,
New Zealand ,
German ,
American ,
West German ,
Sebastian Bauer ,
Jonathan Trent ,
Suzanne George ,
Robinl Jones ,
Matthewl Sherman ,
Translational Sarcoma Research ,
Institute Of Cancer Research ,
Deciphera Pharmaceuticals ,
German Cancer Consortium ,
Dana Farber Cancer Institute ,
Deciphera Pharmaceuticals Inc ,
University Duisburg ,
Sarcoma Center ,
Sylvester Comprehensive Cancer Center ,
American Society Of Clinical Oncology ,
Linkedin ,
Nasdaq ,
Exchange Commission ,
Clinical Research ,
European Union ,
University Hospital Essen ,
Head Of Sarcoma Center ,
German Cancer Center ,
University Of Miami Health System ,
Clinical Oncology ,
Annual Meeting ,
Executive Vice President ,
Chief Medical Officer ,
Consultant Medical Oncologist ,
Royal Marsden ,
Cancer Research ,
Discussion Session ,
Associate Director ,
Miami Health System ,
Associate Division Chief ,
Response Evaluation Criteria ,
Solid Tumors ,
West German Cancer Center ,
University Duisburg Essen ,
Rapid Abstract ,
Private Securities Litigation Reform Act ,
Quarterly Report ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Company ,
Presents ,
Poster ,
N ,
Verall ,
Survival ,
End ,
Safety ,
Results ,
Rom ,
Intrigue ,
Second ,
Analysis ,
Patients ,
Without ,
Mundetectable ,
Ctdna ,
T Dcph Us24344t1016 ,
comparemela.com © 2020. All Rights Reserved.